Abstract
The German Mouse Clinic (GMC) is a large scale phenotyping center where mouse mutant lines are analyzed in a standardized and comprehensive way. The result is an almost complete picture of the phenotype of a mouse mutant line – a systemic view. At the GMC, expert scientists from various fields of mouse research work in close cooperation with clinicians side by side at one location. The phenotype screens comprise the following areas: allergy, behavior, clinical chemistry, cardiovascular analyses, dysmorphology, bone and cartilage, energy metabolism, eye and vision, hostpathogen interactions, immunology, lung function, molecular phenotyping, neurology, nociception, steroid metabolism, and pathology. The German Mouse Clinic is an open access platform that offers a collaboration-based phenotyping to the scientific community (www.mouseclinic.de). More than 80 mutant lines have been analyzed in a primary screen for 320 parameters, and for 95% of the mutant lines we have found new or additional phenotypes that were not associated with the mouse line before. Our data contributed to the association of mutant mouse lines to the corresponding human disease. In addition, the systemic phenotype analysis accounts for pleiotropic gene functions and refines previous phenotypic characterizations. This is an important basis for the analysis of underlying disease mechanisms. We are currently setting up a platform that will include environmental challenge tests to decipher genome – environmental interactions in the areas nutrition, exercise, air, stress and infection with different standardized experiments. This will help us to identify genetic predispositions as susceptibility factors for environmental influences.
Keywords: Phenotype Analysis, Mouse Models, German Mouse Clinic (GMC), cardiovascular analyses, dysmorphology
Current Pharmaceutical Biotechnology
Title: The German Mouse Clinic: A Platform for Systemic Phenotype Analysis of Mouse Models
Volume: 10 Issue: 2
Author(s): H. Behrendt, H. Katus, B. Ivandic, H. Hofler, G. Heldmaier, J. Graw, J. Favor, I. Esposito, H. Daniel, M. Klingenspor, J. Beckers, D. H. Busch, J. Adamski, R. Zeh, M. Willershauser, F. Thiele, R. Steinkamp, C. Sina, P. Rosenstiel, M. Hrabe de Angelis, A. Zimmer, W. Wurst, E. Wolf, H. Schulz, K. Schughart, S. Schreiber, J. Schmidt, A. Schrewe, L. Quintanilla-Martinez, M. Ollert, S. Neschen, W. Muller, M. Mempel, A. Lengeling, T. Klopstock, N. Ehrhardt, A. Javaheri, M. Horsch, G. Holzlwimmer, S. M. Holter, W. Hans, U. Frischmann, B. Ferwagner, N. Fasnacht, M. Kallnik, C. Dalke, J. Calzada- Wack, M. Brielmeier, I. Bolle, L. Becker, J. A. Aguilar Pimentel, T. Adler, V. Gailus-Durner, B. Pasche, R. Schreiner, K. Schable, J. Rozman, B. Rathkolb, I. Racz, O. Puk, G. Przemeck, C. Prehn, H. Fuchs, U. Noth, B. Naton, C. Morth, I. Moβbrugger, H. Maier, C. Lengger and E. Kling
Affiliation:
Keywords: Phenotype Analysis, Mouse Models, German Mouse Clinic (GMC), cardiovascular analyses, dysmorphology
Abstract: The German Mouse Clinic (GMC) is a large scale phenotyping center where mouse mutant lines are analyzed in a standardized and comprehensive way. The result is an almost complete picture of the phenotype of a mouse mutant line – a systemic view. At the GMC, expert scientists from various fields of mouse research work in close cooperation with clinicians side by side at one location. The phenotype screens comprise the following areas: allergy, behavior, clinical chemistry, cardiovascular analyses, dysmorphology, bone and cartilage, energy metabolism, eye and vision, hostpathogen interactions, immunology, lung function, molecular phenotyping, neurology, nociception, steroid metabolism, and pathology. The German Mouse Clinic is an open access platform that offers a collaboration-based phenotyping to the scientific community (www.mouseclinic.de). More than 80 mutant lines have been analyzed in a primary screen for 320 parameters, and for 95% of the mutant lines we have found new or additional phenotypes that were not associated with the mouse line before. Our data contributed to the association of mutant mouse lines to the corresponding human disease. In addition, the systemic phenotype analysis accounts for pleiotropic gene functions and refines previous phenotypic characterizations. This is an important basis for the analysis of underlying disease mechanisms. We are currently setting up a platform that will include environmental challenge tests to decipher genome – environmental interactions in the areas nutrition, exercise, air, stress and infection with different standardized experiments. This will help us to identify genetic predispositions as susceptibility factors for environmental influences.
Export Options
About this article
Cite this article as:
Behrendt H., Katus H., Ivandic B., Hofler H., Heldmaier G., Graw J., Favor J., Esposito I., Daniel H., Klingenspor M., Beckers J., Busch H. D., Adamski J., Zeh R., Willershauser M., Thiele F., Steinkamp R., Sina C., Rosenstiel P., de Angelis Hrabe M., Zimmer A., Wurst W., Wolf E., Schulz H., Schughart K., Schreiber S., Schmidt J., Schrewe A., Quintanilla-Martinez L., Ollert M., Neschen S., Muller W., Mempel M., Lengeling A., Klopstock T., Ehrhardt N., Javaheri A., Horsch M., Holzlwimmer G., Holter M. S., Hans W., Frischmann U., Ferwagner B., Fasnacht N., Kallnik M., Dalke C., Calzada- Wack J., Brielmeier M., Bolle I., Becker L., Aguilar Pimentel A. J., Adler T., Gailus-Durner V., Pasche B., Schreiner R., Schable K., Rozman J., Rathkolb B., Racz I., Puk O., Przemeck G., Prehn C., Fuchs H., Noth U., Naton B., Morth C., Moβbrugger I., Maier H., Lengger C. and Kling E., The German Mouse Clinic: A Platform for Systemic Phenotype Analysis of Mouse Models, Current Pharmaceutical Biotechnology 2009; 10 (2) . https://dx.doi.org/10.2174/138920109787315051
DOI https://dx.doi.org/10.2174/138920109787315051 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities
Recent Patents on Nanotechnology Induction of CYP1A1. The AhR / DRE Paradigm Transcription, Receptor Regulation, and Expanding Biological Roles
Current Drug Metabolism Digitalis-like Compounds: the Discovery of the O-aminoalkyloxime Group as a Very Powerful Substitute for the Unsaturated γ-Butyrolactone Moiety
Current Medicinal Chemistry Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Organophosphorus Compounds: Intervention in Mechanisms of Signal Transduction Relevant to Proliferative, Immunological and Circulatory Disorders
Current Medicinal Chemistry Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Current Neuropharmacology The Synthesis, Structural Study and Anticancer Activity Evaluation of Emodin Derivatives Containing Conjugative Groups
Medicinal Chemistry G Protein β γ Subunits as Targets for Small Molecule Therapeutic Development
Combinatorial Chemistry & High Throughput Screening Recent Developments in Tumor Angiogenesis
Current Pharmaceutical Biotechnology Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug Targets Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry Leptin Signaling in Blood Platelets as a Target for Therapeutic Intervention
Current Signal Transduction Therapy Does Cyclic Dependent Kinase 5 Play a Significant Role in Determination of Stroke Outcome? Possible Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Current Pharmaceutical Design Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy
Current Pharmaceutical Design Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Cancer Stem Cell Markers in Nasopharyngeal Carcinoma and Its Relevance for Therapy
Current Traditional Medicine Recent Studies and Biological Aspects of Substantial Indole Derivatives with Anti-cancer Activity
Current Organic Chemistry